Newcastle disease virus activated human peripheral blood mononuclear cells and their use in cancer therapy.
This invention provides a method for immune activation of human peripheral blood mononuclear cells (PBMC) by treatment with immunogens derived from New Castle Disease virus (NDV). The invention describes a method of activation of PBMC by NDV, the activated PBMCs produced by the inventive method as w...
| Main Authors: | , , , , |
|---|---|
| Format: | Patent |
| Published: |
2010
|